E45

E45
Routes of administration	Topical

E45 is a prominent brand of emollient and moisturizing skincare products, widely recognized for the management of dry and problematic skin conditions. First developed in the United Kingdom, the range has become a staple in dermatological care across many countries. Its formulations are designed to soothe, protect, and hydrate the skin, making it a first-line recommendation from healthcare professionals.

Overview

The E45 product line was originally created by Crookes Healthcare, a subsidiary of the larger Reckitt Benckiser group, and is now owned by Thornton & Ross. Its name is derived from its original formulation, which was the 45th experimental batch developed by researchers. The brand's hallmark is its simple, effective formulations often centered around key ingredients like white soft paraffin, light liquid paraffin, and wool alcohols. These products are available in various forms, including creams, lotions, and ointments, and are sold over-the-counter in pharmacies and supermarkets. The brand's reputation for gentle efficacy has made it a trusted household name in dermatology.

Medical uses

E45 creams and ointments are primarily indicated for the treatment of dry, itchy, or scaly skin conditions. They are frequently recommended for managing symptoms of eczema (atopic dermatitis), psoriasis, and ichthyosis. Healthcare providers often suggest its use to alleviate the discomfort of contact dermatitis and severely dry skin (xerosis). Furthermore, E45 products are commonly used as adjunctive therapy, helping to repair the skin's barrier function during and after treatment with topical corticosteroids or calcineurin inhibitors. They are also utilized for preventing and treating radiation dermatitis in patients undergoing radiotherapy.

Side effects

E45 products are generally well-tolerated due to their non-irritating, fragrance-free formulations. However, as with any topical product, there is a potential for adverse reactions. The most commonly reported side effect is a localized skin reaction, such as mild stinging, redness, or a burning sensation upon application, particularly on broken or inflamed skin. Allergic contact dermatitis is rare but possible, potentially due to sensitivity to components like lanolin (wool alcohols). Patients are advised to discontinue use and consult a general practitioner or dermatologist if any severe irritation or rash develops. There is minimal risk of systemic side effects due to negligible absorption through the skin.

Pharmacology

The pharmacological action of E45 is primarily physical rather than biochemical. Its key ingredients, white soft paraffin and light liquid paraffin, are occlusive agents that form a protective hydrophobic film on the stratum corneum. This film reduces transepidermal water loss (TEWL), effectively trapping moisture within the skin. The formulations often contain humectants which help to attract and bind water. By hydrating the epidermis and supporting the lipid barrier, E45 aids in restoring skin plasticity, reducing scaling, and relieving pruritus. Its mechanisms do not involve direct interaction with inflammatory pathways like those targeted by dexamethasone or tacrolimus.

Society and culture

Within the National Health Service in the United Kingdom, E45 is often prescribed or recommended, making it a culturally ingrained product in British healthcare. Its distinctive packaging and branding are instantly recognizable. The brand has been referenced in popular culture, including television shows and literature, often as a shorthand for a common remedy for minor skin ailments. E45 has also been the subject of advertising campaigns featuring endorsements from dermatology nurses and general practitioners, reinforcing its medical credibility. Its widespread availability and affordability have cemented its role in public health management of chronic skin conditions.

Research

Ongoing research into emollient therapy continues to validate the role of products like E45. Clinical studies, such as those published in the British Journal of Dermatology, have demonstrated the efficacy of paraffin-based creams in improving skin hydration and reducing flares of atopic eczema in both children and adults. Comparative research often pits E45 against other major brands like Cetraben or Diprobase to assess cost-effectiveness and patient preference. Current investigations are exploring its potential in preventing the development of food allergies in high-risk infants with eczema, a hypothesis linked to the integrity of the skin barrier. Further studies examine novel formulations with added ceramides or anti-microbial agents.

Category:Dermatology Category:Topical drug formulations Category:British brands